The majority of patients eligible for cancer immunotherapy drugs known as checkpoint inhibitors received treatment within a few months of FDA approval, according to a new Yale-led study.
In a phase III trial of Lonsurf (trifluridine and tipiracil) plus best supportive care versus placebo plus BSC in patients with previously treated metastatic gastric cancer, the Lonsurf-containing arm met the primary endpoint of prolonged overall survival.
According to the Oncology Nursing Society's new position statement, “Role of the Oncology Nurse Navigator Throughout the Cancer Trajectory,” oncology nurse navigators are crucial to the successful outcomes of patients with cancer. Through clinical expertise, care coordination skills, and leadership abilities, ONNs are able to guide their patients during the cancer trajectory.
The FY18 Defense Appropriation provides $15 million to the Department of Defense Kidney Cancer Research Program to support the United States Medical Research Acquisition Activity.
The American Cancer Society and the Melanoma Research Alliance selected the first group of scientists to receive newly established research grants to investigate how to reduce side effects resulting from cancer treatments with checkpoint inhibitors.
The Cholangiocarcinoma Foundation and Komodo Health announced an agreement linking a cancer advocacy group with a healthcare analytics and insights delivery company to advance the treatment of cholangiocarcinoma.
Generic drug options did not significantly reduce prices paid for the cancer therapy imatinib (Gleevec), according to a Health Affairs paper published May 10.
The data available to US Preventive Services Task Force didn't address an important question: what do you recommend to African American men who are twice as likely to develop prostate cancer and die from it as the general population?
Health care organizations and companies representing patients, providers, laboratories and diagnostic manufacturers called on Senate and House leaders to advance legislation that would reform and modernize the process for bringing innovative diagnostics and clinical laboratory tests to market.
The White House May 11 proposed a series of policy initiatives to reduce the prices of prescription drugs.
